AGER and chronic myelogenous leukemia, BCR-ABL1 positive: Specifically, RAGE expression was significantly increased in presence of CML treatment (3.18, 95% CI: 2.29 - 4.07, p ≤ 0.0001) compared to OC (1.15, 95% CI: 1.00 - 1.31, p ≤ 0.001).